Table 6.

Clinical presentation and clonal cytogenetic abnormalities in patients with t-MDS/t-AML


Presentation

No. patients

Abnormality 5 (%)

Abnormality 7 (%)

Abnormalities 5 and 7 (%)

Balanced rearrangement (%)

Other abnormalities (%)

Normal (%)
t-MDS→unknown   54   10 (19)   20 (37)   9 (17)   2 (4)   7 (13)   6 (11)  
t-MDS only   72   19 (26)   16 (22)   17 (24)   0   11 (16)   9 (13)  
t-MDS→t-AML   98   19 (19)   32 (33)   28 (29)   6 (6)   9 (9)   4 (4)  
t-AML only   82   14 (17)   16 (20)   12 (15)   23 (28)   12 (15)   5 (6)  
Totals
 
306
 
62 (20)
 
84 (27)
 
66 (22)
 
31 (10)
 
39 (13)
 
24 (8)
 

Presentation

No. patients

Abnormality 5 (%)

Abnormality 7 (%)

Abnormalities 5 and 7 (%)

Balanced rearrangement (%)

Other abnormalities (%)

Normal (%)
t-MDS→unknown   54   10 (19)   20 (37)   9 (17)   2 (4)   7 (13)   6 (11)  
t-MDS only   72   19 (26)   16 (22)   17 (24)   0   11 (16)   9 (13)  
t-MDS→t-AML   98   19 (19)   32 (33)   28 (29)   6 (6)   9 (9)   4 (4)  
t-AML only   82   14 (17)   16 (20)   12 (15)   23 (28)   12 (15)   5 (6)  
Totals
 
306
 
62 (20)
 
84 (27)
 
66 (22)
 
31 (10)
 
39 (13)
 
24 (8)
 

P < .0001. Two patients, one each with abnormal chromosome 5 or 7, are counted only in the balanced rearrangement category because of t(3;21) or inv(16).

or Create an Account

Close Modal
Close Modal